Novassay is a privately owned Swiss-based Biotechnology company established in 2013. Ion Channels and their involvement in biological processes and as causative factors of certain morbidities are the primary focus of the company. Novassay is offering R&D discovery services and pursuing drug development programs in Neuropathic Pain and Oncology where ion channels seem to be playing a pivotal role.